Press Releases Raffles Medical Group Announces 1H2023 Results with S$60.4 Million Profit After Tax July 31, 2023 Condensed Interim Financial Statements for the Six Months Ended 30 June 2023 July 31, 2023 Raffles Medical Group Reports Profit After Tax of S$143.7 Million, Increased 71.7 Per Cent February 27, 2023 Full Year Financial Statement for the Year Ended 31 December 2022 February 27, 2023 Raffles Reports Revenue of S$199.5M and PAT of S$38.3M October 31, 2022 Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions October 3, 2022 Condensed Interim Financial Statements for the Six Months Ended 30 June 2022 August 1, 2022 Raffles Reports Revenue of S$382.3M and PAT of S$60M; Opening of In-Vitro Fertilisation/Assisted Reproductive Therapy Centre at Le Cheng, Hainan August 1, 2022 Full Year Financial Statement and Related Announcement For The Year Ended 31 December 2021 February 21, 2022 Raffles Medical Group Reports Record Revenue of S$723.8 Million and Profit After Tax of S$83.7 Million February 21, 2022 1 2 3 … 22 Next » Search by Title Search by Date
Raffles Medical Group Reports Profit After Tax of S$143.7 Million, Increased 71.7 Per Cent February 27, 2023
Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions October 3, 2022
Raffles Reports Revenue of S$382.3M and PAT of S$60M; Opening of In-Vitro Fertilisation/Assisted Reproductive Therapy Centre at Le Cheng, Hainan August 1, 2022
Full Year Financial Statement and Related Announcement For The Year Ended 31 December 2021 February 21, 2022
Raffles Medical Group Reports Record Revenue of S$723.8 Million and Profit After Tax of S$83.7 Million February 21, 2022
